维普期刊资源整合服务平台（V6.5）

192篇 您的检索式：作者名="GERICH J"

选中清除导出查看参考文献查看引证文献引用追踪共10页首页上一页第1页下一页末页 /10 跳转

	题名	作者	年代	出处	被引量
1	The Treat-to-TargetTrial: randomised addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients显示文摘	RiddleMC Rosenstock J Gerich J	2003	Diabetes Care2003，26，11：	1
2	Fluctuat of serum basal insulin levels following single and multiple dosing of insulin glargine显示文摘	Gerich J Becker RH Zhu R	2006	Diabetes Technol Ther2006，8，2：	1
3	The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients显示文摘	Riddle M C Rosenstock J Gerich J	2003	Diabetes Care2003，26，2：	1
4	Efficacy and safety of the humanglucagon-like peptide-1 analog liraglutide in combination with metformin andthiazolidinedione in patients with type 2 diabetes 显示文摘	Zinman B Gerich J Buse JB	2009	Diabetes Care2009，32，：	1
5	The treatto-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients显示文摘	Riddle MC Rosenstock J Gerich J	2003	Diabetes Care2003，26，11：	1
6	The treat-to-target trail:Randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients显示文摘	Riddle Mc Rosenstock J Gerich J	2003	Diabetes Care2003，26，：	1
7	Glucose counterregulation,hypoglycemia and intensive insulin therapy in diabetes mellitus显示文摘	CRYER P E GERICH J E	1985	N Engl J Med1985，313，：	1
8	Is reduced first-phase insulin release the earliest detectable abnormality in individuals destined to develop type 2 diabetes? 显示文摘	Gerich J E	2002	Diabetes2002，51，1：	1
9	Efficacy and safety of thehuman glucagon-like peptide-1 analog liraglutide in combination with metformin and thiazolidinedione in patientswith type 2 diabetes(LEAD-4 Met+TZD)显示文摘	Zinman B Gerich J Buse JB	2009	Diabetes Care2009，32，7：	1
10	Efficacy and safety of the human glucagon-like peptide-1 analog liraglutide in combination with mefformin and thiazolidinedione in patients with type 2 diabe- tes (LEAD-4 Met + TZD) 显示文摘	Zinman B Gerich J Buse JB	2009	Diabetes Care2009，32，7：	1
11	The treat-to-target trial:randomized addition of glargine or human NPH insulin to oral theraoy of type 2 diabetic patients显示文摘	Riddle M C Rosenstock J Gerich J	2003	Diabetes Care2003，26，11：	1
12	The treat-to-tar- get trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patinents显示文摘	Riddle MC Rosenstock J Gerich J	2003	Dia- betes Care2003，26，11：	1
13	Fluctuation of serum basal insulin levels following single and multiple dosing of insulin glargine显示文摘	Gerich J Beeker RH Zhu R	2006	Diabetes Technol Ther2006，8，2：	1
14	The genetic basis of type 2 diabetes mellitus: impaired insulin secretion versus impaired insulin sensitivity 显示文摘	GERICH J E	1998	Endoer Rev1998，，19：	1
15	Postprandial hyperglycemia and cardiovascular disease显示文摘	Gerich J	2006	Endocr Pratt2006，12，1：	1
16	Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes显示文摘	Riddle MC Rosenstock J Gerich J	2005	Diabetes Care2005，28，2：	1
17	The treal-to-target trial ranaomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetes patients 显示文摘	Riddle MC Rosenstock J Gerich J	2003	Diabetes Care2003，26，11：	1
18	Clinical features of insulin resistance and beta cell dysfunction and the relationship to type 2 diabetes显示文摘	Stumvoll M Gerich J	2001	Clin Lab Med2001，21，：	1
19	Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes显示文摘	Riddle MC Rosenstock J Gerich J		0，，02：	1
20	Guideline for manageme- nt of postmeal glucose显示文摘	Ceriello A Colagiuri S Gerich J	2008	Nutr Metab Cardiovasc Dis2008，18，4：	1

返回顶部每页显示：

共10页首页上一页第1页下一页末页 /10 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示